Director, Alzheimer's Global Commercial Strategy & Commercial Development

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it.

Position Summary:

The Director, Neurodegeneration, Strategy & Commercial Development will work under the direction of the Executive Director, Neurodegeneration to lead efforts supporting Alzheimer's Disease strategy, pipeline, and market development.

This position will help guide strategic assessments and be responsible for integrating strategic recommendations across the Alzheimer's franchise to maximize opportunities and value.

Strategy responsibilities include helping to define the scope of Alzheimer's opportunities based on the future evolution of unmet need, treatment landscape and competitive pipeline, pricing and access dynamics, and the underlying science. Deliverables include Target Opportunity Profiles, Patient Journeys, and Customer Segmentation strategies for Alzheimer's Disease.

This position is also responsible for supporting the development and execution of strategies for Alzheimer's pipeline assets, under the direction of the Executive Director. (S)he will help optimize the value of key Alzheimer's products, identifying areas for growth and seeking opportunities within and beyond the organization to add value to long-term plans. This position will support representation of Alzheimer's products on the Global Program Team.

In addition, this position is responsible for supporting Market Development activities for Alzheimer's Disease – engaging with cross-functional matrix partners and local markets to help develop and deliver the brand strategy that establishes strategic platforms for optimizing Alzheimer's assets, and to prepare markets for launch. This includes helping to inform scientific branding and brand development and working with Medical colleagues to build relationships with key external stakeholders, patient advocacy organizations, medical societies, and thought leaders in Alzheimer's Disease.

This role will engage with the Neurology community to support continued investment in the Alzheimer's strategy to help drive disease recognition and diagnosis including biomarker evolution. The successful candidate will partner with Medical, MAx, R&D, Advocacy, and selected country leads, under the guidance of the Executive Director, to ensure the Alzheimer's market development strategy is aligned, developed through market insights, and actionable across geographies.

The Director will have a passion for understanding the science underlying Alzheimer's Disease and drug development and commercialization. This requires the ability to establish strong partnerships with R&D, Medical, Business Insights & Analytics (BI&A), Business Development, Market Access, Pricing and Reimbursement (MAx), and other commercial colleagues, in support of the overall neurodegeneration strategy.

The person must be able to operate in a fast-paced organization, with high expectations and accountability on quality of deliverables and the ability to contribute to an energizing, inclusive culture. Demonstrated ability to lead and influence without direct authority across functions, including Clinical, Regulatory, MAx, Medical, BI&A, and other key cross-functional Commercial partners, is required.

Domestic and International travel required (~20%).

Key Responsibilities:

Supports the Executive Director in developing Alzheimer's Disease strategy, pipeline recommendations, and market development plans

Leads development of Alzheimer's market opportunity assessments and asset-level commercialization deliverables, including TOPs and patient journeys

Helps drive the Strategic Planning process across R&D, Commercialization, and enabling functions for the Alzheimer's franchise

Responsible for identifying challenges and solutions related to adopting novel treatments in Alzheimer's Disease

Supports Alzheimer's market development activities, including clarifying paths to patient identification based on biomarkers and other factors, and biomarker adoption as endpoints

Serves as liaison with key external Alzheimer's influencers on guidelines and policy-shaping efforts, including cross-industry coalitions

Helps clarify the investments needed to increase diagnosis and shape product selection through biomarker adoption and diagnostic requirements for Neurologists, Psychiatrists, PCPs, and Geriatricians

Helps inform brand planning across marketing, medical, and access for Alzheimer's assets

Partners with opinion leaders, advocacy groups, and other stakeholders, external agencies, and vendors to reinforce BMS's commitment to Alzheimer's Disease

Ensures comprehensive assessment of competitive data and events, and integrates implications into Alzheimer's brand strategy and plans

Partners with the WW Value, Access, and Pricing team as needed to support the Alzheimer's value story

Supports optimization of the commercialization model, driving pull-through of global launch strategies to local affiliates as relevant

Builds a deep understanding of local market dynamics, including customer and competitive insights, to inform Alzheimer's commercialization and launch planning

Key Qualifications & Experience:

BA/BS required; life sciences degree or equivalent desirable. MBA / graduate degree highly preferred

8–10 years of progressive industry experience, including demonstrated marketing experience

Proven track record of commercial expertise across products in various stages of development, from pipeline to launch to in-market, preferred

US and Global experience preferred

Functional experience within Neuroscience, and specifically Alzheimer's Disease/Dementia, strongly preferred

Demonstrated scientific acumen; understanding of drug development processes and regulatory pathways, product design, and new product evaluation

Understanding of the commercial aspects of drug development, including global/country market dynamics, operational feasibility, market access, patient advocacy, and regulatory and reimbursement challenges across domestic and international markets

Collaborates across the organization to incorporate the needs of internal and external stakeholders in the commercial planning process

Ability to critically assess opportunities with disciplined thinking to determine what is best for patients and the business, and to influence and build alignment with stakeholders

Strong financial acumen, with the ability to assimilate complex information to create and manage budgets and meet financial targets

Proven track record demonstrating breadth and depth of experience across marketing competencies and exemplary achievement of performance objectives

Demonstrated experience leading strategically, communicating with impact, and contributing to a strong, inclusive, energizing culture consistent with BMS values

Experience mobilizing matrix team members and embracing teamwork within a cross-functional environment

Knowledge of AI resources and how to utilize to enhance productivity and quality outputs.

We hire for skills and capabilities, not just credentials – if this role excites you, but doesn’t perfectly match your resume, we encourage you to apply anyway.

Compensation Overview:

• Princeton - NJ - US: $196,950 - $238,661 

• The starting pay range(s) listed above is for full-time employees (FTE). You may also be eligible for additional discretionary incentive cash and stock opportunities. We determine starting pay thoughtfully – carefully considering the nature of the